Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00960206 · ClinicalTrials.gov registry record · NA
ABC/Trident® Ceramic Post Approval Study
A NA study, sponsored by Stryker Orthopaedics.
- Completed
- Registry status
- NA
- Development phase
- 413
- Enrollment target
NCT00960206: Completed NA study, sponsored by Stryker Orthopaedics.
NCT00960206 is a NA study that has completed, run by Stryker Orthopaedics. The registered enrollment target is 413 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (71% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00960206, a NA study, has completed, sponsored by Stryker Orthopaedics.
- COMPLETED
- Registry status
- NA
- Development phase
- 413 participants
- Enrollment target
Study Summary
The purpose of the Post Approval Study of the ABC and Trident® systems is to continue to demonstrate the safety and efficacy of the alumina-on-alumina bearing surfaces combined with the appropriate shell in a cementless application.
Primary Outcome
The number of hips in which the study device was removed and replaced with a new component/s is listed. Complications (adverse events) are listed in the adverse event section.
Interventions
- DEVICE Trident® Ceramic Insert/Trident® AD HA Acetabular Shell
- DEVICE Alumina Insert/PSL® Microstructured Acetabular Shell or Secur-Fit® HA PSL® Acetabular Shell
- DEVICE OmniFit® Series II Insert/OmniFit® PSL® Microstructured Acetabular Shell
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 413 participants |
| Start Date | 2003-03 |
| Est. Completion | 2010-10 |
| Phase | NA |
What the finished NCT00960206 record still lists
NCT00960206 is an interventional study that assigns participants to a tested intervention. The registered 413 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (71% lower).
The record links to 0 conditions, and to 3 interventions - of which Trident® Ceramic Insert/Trident® AD HA Acetabular Shell is the first listed.
NCT00960206 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00960206 about?
NCT00960206 is a clinical study titled "ABC/Trident® Ceramic Post Approval Study". The purpose of the Post Approval Study of the ABC and Trident® systems is to continue to demonstrate the safety and efficacy of the alumina-on-alumina bearing surfaces combined with the appropriate shell in a cementless application.
What is the current status of trial NCT00960206?
This trial is currently completed. It is a NA study. The enrollment target is 413 participants. The study started on 2003-03. Estimated completion is 2010-10.
What interventions are being tested in trial NCT00960206?
The interventions under investigation include: Trident® Ceramic Insert/Trident® AD HA Acetabular Shell (DEVICE), Alumina Insert/PSL® Microstructured Acetabular Shell or Secur-Fit® HA PSL® Acetabular Shell (DEVICE), OmniFit® Series II Insert/OmniFit® PSL® Microstructured Acetabular Shell (DEVICE).
Who is sponsoring clinical trial NCT00960206?
This trial is sponsored by Stryker Orthopaedics, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00960206's enrollment target sits among peer trials
413 241st of 2000 higher than 1,760 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03592472 · 413 participants · Phase 3
A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)
- NCT06697197 · 413 participants · Phase 1
A Study of BMS-986482 Alone or as Combination Therapy in Participants With Advanced Solid Tumors
- NCT04776941 · 414 participants · NA
Expressive Writing for the Management of Stress in Cancer Survivors
- NCT06792552 · 414 participants · Phase 1
A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia